ABCG2 and lung carcinoma: By pumping chemotherapeutic medications out of cells and lowering the concentration of intracellular pharmaceuticals, ABCG2 significantly increased the chemotherapy resistance of lung cancer stem cells (Huang and Fu, 2015) (Figure 2).